Article Information
History
- April 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Leire de Campos-Mata1,
- Sonia Tejedor Vaquero1,
- Roser Tachó-Piñot1,
- Janet Piñero2,
- Emilie K. Grasset3,
- Itziar Arrieta Aldea4,
- Natalia Rodrigo Melero5,
- Carlo Carolis5,
- Juan P. Horcajada4,
- Andrea Cerutti1,3,6,
- Judit Villar-García4 and
- Giuliana Magri1,*
- 1Translational Clinical Research Program, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain
- 2Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
- 3Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- 4Department of Infectious Diseases, Hospital Del Mar, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), 08003, Barcelona, Spain
- 5Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader, 88, 08004 Barcelona
- 6Catalan Institute for Research and Advanced Studies (ICREA), 08003 Barcelona, Spain
- ↵*Correspondence to gmagri{at}imim.es (G.M.)
Posted April 30, 2021.
SARS-CoV-2 sculpts the immune system to induce sustained virus-specific naïve-like and memory B cell responses
